Henry Schein reported third-quarter GAAP diluted earnings per share of $1.06, a 26.2% increase year-over-year, driven by strong U.S. dental merchandise sales growth of 8.6%. Total net sales reached $3.5 billion, reflecting 4.0% total growth and 3.1% internal growth in local currencies. The company raised its full-year non-GAAP diluted EPS guidance to a range of $5.50 to $5.56 from the previous estimate of $5.29 to $5.39, citing strong operating performance, net tariff refund benefits, and targeted growth investments. Adjusted EBITDA for the quarter was $321 million, up from $295 million in the prior-year period. Additionally, the company repurchased approximately 1.4 million shares of common stock for $125 million during the quarter.
